These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15772514)

  • 21. Summaries for patients. A combination treatment for pulmonary hypertension.
    Ann Intern Med; 2008 Oct; 149(8):I-38. PubMed ID: 18936497
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Unexplained pulmonary arterial hypertension in a patient with lung resection, treated with sildenafil and beraprost].
    Shimokawa M; Sakamaki F; Aoki T; Yogo Y; Ebihara A
    Nihon Kokyuki Gakkai Zasshi; 2006 Nov; 44(11):817-22. PubMed ID: 17144579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.
    Matamis D; Pampori S; Papathanasiou A; Papakonstantinou P; Tsagourias M; Galiatsou E; Koulouras V; Nakos G
    Circ Heart Fail; 2012 Jan; 5(1):47-53. PubMed ID: 22057829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beraprost therapy for pulmonary arterial hypertension.
    Barst RJ; McGoon M; McLaughlin V; Tapson V; Rich S; Rubin L; Wasserman K; Oudiz R; Shapiro S; Robbins IM; Channick R; Badesch D; Rayburn BK; Flinchbaugh R; Sigman J; Arneson C; Jeffs R;
    J Am Coll Cardiol; 2003 Jun; 41(12):2119-25. PubMed ID: 12821234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.
    Binns-Loveman KM; Kaplowitz MR; Fike CD
    Pediatr Pulmonol; 2005 Jul; 40(1):72-80. PubMed ID: 15880376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost A; Engel P; Kramer MR; Serdarevic-Pehar M; Layton GR; Sitbon O; Badesch DB;
    J Heart Lung Transplant; 2014 Jul; 33(7):689-97. PubMed ID: 24815795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined treatment with intravenous prostacyclin and sildenafil in patients with pulmonary hypertension: report of 4 cases].
    García Hernández FJ; Ocaña Medina C; Mateos Romero L; Martínez Martínez A; Bautista Lorite A; Santos Ramos B; Sánchez Román J
    Med Clin (Barc); 2004 Jan; 122(2):64-6. PubMed ID: 14733859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
    Galiè N; Humbert M; Vachiéry JL; Vizza CD; Kneussl M; Manes A; Sitbon O; Torbicki A; Delcroix M; Naeije R; Hoeper M; Chaouat A; Morand S; Besse B; Simonneau G;
    J Am Coll Cardiol; 2002 May; 39(9):1496-502. PubMed ID: 11985913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery.
    Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
    Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J
    Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
    Rosengarten B; Schermuly RT; Voswinckel R; Kohstall MG; Olschewski H; Weissmann N; Seeger W; Kaps M; Grimminger F; Ghofrani HA
    Cerebrovasc Dis; 2006; 21(3):194-200. PubMed ID: 16388195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension.
    Lobato EB; Beaver T; Muehlschlegel J; Kirby DS; Klodell C; Sidi A
    Br J Anaesth; 2006 Mar; 96(3):317-22. PubMed ID: 16443640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
    Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S
    Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of pulmonary hypertension with beraprost and sildenafil after cord blood transplantation for infantile leukemia.
    Kawashima N; Ikoma M; Sekiya Y; Narita A; Yoshida N; Matsumoto K; Hatano T; Kato K
    Int J Hematol; 2013 Jan; 97(1):147-50. PubMed ID: 23243005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
    Melian EB; Goa KL
    Drugs; 2002; 62(1):107-33. PubMed ID: 11790158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.